Rishabh Gupta | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Mr. Rishabh Gupta | Pharmacology
| Young Scientist Award

Jagannath University, Jaipur | India

Mr. Rishabh Gupta’s research focuses on advancing pharmaceutical sciences through innovative drug formulation and delivery approaches, emphasizing the use of advanced analytical and instrumental techniques such as UV-spectrophotometry, dissolution apparatus, and rotavapour for precision-based pharmaceutical analysis. His ongoing doctoral research in pharmaceutical sciences explores novel strategies for optimizing drug solubility, stability, and bioavailability to enhance therapeutic outcomes. With a strong foundation in pharmaceutics, he contributes to preclinical and formulation development studies involving animal handling, dosing, and pharmacokinetic analysis, ensuring translational relevance between laboratory findings and clinical applications. His academic engagement extends to guiding research projects on innovative dosage forms, controlled drug delivery systems, and evaluation methodologies that address current challenges in the pharmaceutical industry. Through a multidisciplinary approach combining formulation science, analytical validation, and data-driven interpretation using computational tools like MS Excel, Rishabh Gupta strives to integrate scientific rigor with practical application. His work also aligns with contemporary pharmaceutical research trends, such as the development of patient-centric formulations, biopharmaceutical characterization, and regulatory compliance in drug development. By bridging academic research and applied pharmaceutical innovation, his contributions aim to strengthen evidence-based practices and foster advancements in drug formulation science for improved patient care and therapeutic efficacy.

Featured Publications

Pal, R., Pandey, P., Jha, D., Dutta, P., Sahoo, S., Gupta, R., Rizwan, M., et al. (2023). The utilization of full factorial design (FFD) for optimization of lincomycin hydrochloride (LNH) loaded nanogel involving design of experiments (DoE) and evaluation parameters. Advances in Research on Teaching, 24(6), 272–281.

 Gupta, R., & Singhal, M. (2022). Transferosomes as an efficient carrier system for better therapeutic response of targeted drug delivery system. Research Journal of Pharmacy and Technology, 15(2), 913–920.

 Gupta, R., Dhiman, S., Agrawal, C., Sharma, S., & Singh, T. G. (2024). Formulation and evaluation of nateglinide-loaded nanostructured lipid carriers for sustained release. AIP Conference Proceedings, 3209(1), 060022. https://doi.org/10.1063/5.0212345 (Add DOI if available)

Gupta, R., Pal, R., Ghosh, B., Sharma, S., Himanshi, J., & Sharma, S. (2025). Chapter 10: Regulatory, ethical and current status (clinical trials & patents) in nano-brain drug delivery. In Nano-Brain Revolution in Alzheimer’s Disease – A New Era of Brain Drug Delivery (pp. [insert pages if known]).

Dharmalingam Kirubakaran | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Dharmalingam Kirubakaran l Pharmacology
| Young Scientist Award

Saveetha University | India

Dr. Dharmalingam Kirubakaran’s research focuses on the green synthesis of nanoparticles and their multifaceted biomedical applications, encompassing antioxidant, antibacterial, anti-inflammatory, antidiabetic, and anticancer activities. His work extensively explores plant-mediated nanoparticle synthesis using bioactive extracts from species such as Strobilanthes cordifolia, Acmella caulirhiza, Cajanus albicans, Lantana camara, and Mangifera indica, combining traditional phytochemistry with advanced nanotechnology approaches. Characterization techniques employed include UV-Visible spectrophotometry, Fourier Transform Infrared (FTIR) spectroscopy, X-ray Diffraction (XRD), Scanning and Transmission Electron Microscopy (SEM/TEM), Energy Dispersive Spectroscopy (EDAX), and Dynamic Light Scattering (DLS), ensuring comprehensive analysis of particle morphology, size, and stability. Complementing synthesis studies, his in vitro assessments encompass antibacterial activity against Gram-positive and Gram-negative bacteria, antioxidant assays such as DPPH, ABTS, H₂O₂, and FRAP, anti-inflammatory and antidiabetic evaluations, anticholinergic enzyme inhibition, and anticancer effects on multiple cell lines including MCF-7, A431, HeLa, and A549. Additional investigations include mosquito larvicidal bioassays, photocatalytic dye degradation, and ethnobotanical studies of medicinal plants. His publications reveal a strong emphasis on sustainable, plant-based nanomaterials for biomedical applications, with work on PVA–PEG and chitosan-based nanocomposites highlighting potential in food packaging, therapeutic interventions, and drug delivery. Collectively, his research integrates phytochemistry, nanotechnology, and pharmacological evaluation to advance environmentally friendly and biologically effective solutions for healthcare and environmental challenges.

Featured Publications

  • Kirubakaran, D., Wahid, J. B. A., Karmegam, N., Jeevika, R., Sellapillai, L., … (2025). A comprehensive review on the green synthesis of nanoparticles: Advancements in biomedical and environmental applications. Biomedical Materials & Devices, 1–26.

  • Manimegalai, P., Selvam, K., Loganathan, S., Kirubakaran, D., Shivakumar, M. S., … (2024). Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaf extract of Hardwickia binata: Their characterizations and biological applications. Biomass Conversion and Biorefinery, 14(11), 12559–12574.

  • Kirubakaran, D., Selvam, K., Prakash, P., Shivakumar, M. S., Rajkumar, M. (2023). In-vitro antioxidant, antidiabetic, anticholinergic activity of iron/copper nanoparticles synthesized using Strobilanthes cordifolia leaf extract. OpenNano, 14, 100188.

  • Rajkumar, M., Presley, S. I. D., Govindaraj, P., Kirubakaran, D., Farahim, F., Ali, T., … (2025). Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and … Scientific Reports, 15(1), 3931.

  • Kirubakaran, D., Bupesh, G., Wahid, J. B. A., Murugeswaran, R., Ramalingam, J., … (2025). Green synthesis of zinc oxide nanoparticles using Acmella caulirhiza leaf extract: Characterization and assessment of antibacterial, antioxidant, anti … Biomedical Materials & Devices, 1–22.

Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Published on by Young Scientists Awards

Prof. Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Professor Faisal Al-Akayleh, an editorial board member of the Jordan Journal of Pharmaceutical Sciences.  university of Petra, Jordan

🌟 Professor Faisal T. Al-Akayleh, Ph.D. is a distinguished expert in pharmaceutics and pharmaceutical technology, serving as the Head of the Department of Pharmaceutics and Pharmaceutical Technology at the University of Petra, Amman, Jordan. With a robust academic and professional background, Professor Al-Akayleh has made remarkable contributions as a pharmaceutical researcher, inventor, and consultant. He has authored five patents in the fields of nanotechnology, pharmaceutical science, and environmental applications. His innovative spirit is reflected in his leadership roles and impactful projects in drug delivery and nanotechnology. 💊🔬

Publication Profile

Education

🎓 Ph.D. in Pharmaceutics and Pharmaceutical Technology – Professor Al-Akayleh’s academic journey is marked by his expertise in pharmaceutics, enabling him to advance the pharmaceutical industry with groundbreaking innovations. His education laid the foundation for his significant contributions to pharmaceutical technology and material science. 📚

Experience

📈 With years of experience in academia and the pharmaceutical industry, Professor Al-Akayleh has served as a technical manager and consultant for various pharmaceutical companies. As an associate professor, he has led groundbreaking research projects and collaborated on numerous industry-funded initiatives. His leadership extends to his roles as a board member of the Jordan Journal of Pharmaceutical Sciences and the University of Petra Pharmaceutical Center. He also chairs the Ethical Approval Committee at the University of Petra. 🧪

Awards and Honors

🏆 Professor Al-Akayleh received the prestigious El Hassan Bin Talal Award for Scientific Excellence (2018) for his collaborative project on developing an oral insulin delivery system. His dedication to innovation has garnered recognition for advancing pharmaceutical research and development. ✨

Research Focus

🔍 Professor Al-Akayleh specializes in drug delivery systems, nanotechnology, pharmaceutical material science, and environmental sustainability. His research addresses critical challenges in developing innovative drug formulations, including nanoparticles for improved skin permeation and novel excipients for enhanced drug delivery. 🌐

Conclusion

Professor Faisal T. Al-Akayleh is a trailblazer in pharmaceutical sciences, combining academic excellence with industrial expertise to deliver innovative solutions. His commitment to advancing pharmaceutics and nanotechnology continues to inspire scientific progress and foster meaningful collaborations. 🌟

Publications

Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals (2024)
Published in Pharmaceuticals, cited by 10 articles.

Novel therapeutic deep eutectic system for the enhancement of ketoconazole antifungal activity and transdermal permeability (2024)
Published in Journal of Molecular Liquids, cited by 15 articles.

AI-Driven Physical Rehabilitation Strategies in Post-Cancer Care (2024)
Presented at IEEE ICCR 2024 Conference, cited by 5 articles.

What We Know About the Actual Role of Traditional Probiotics in Health and Disease (2024)
Published in Probiotics and Antimicrobial Proteins, cited by 12 articles.

Utilizing olive leaves biomass as an efficient adsorbent for ciprofloxacin removal (2024)
Published in Environmental Monitoring and Assessment, cited by 8 articles.